Welltower Inc. (0LUS)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 237.10 |
|---|---|
| 52-week range | 41.55 – 264.70 |
| Return, 1 month / 3 months | +2.8% / −3.3% |
| Return, 1 year / 3 years | +37.3% / +198.7% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 247.0% |
| Worst drawdown (1 year) | -83.4% |
| Average daily value traded | 0.21M USD |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure, chiefly senior housing and post-acute care properties. The company owns and develops buildings that it leases to experienced operators who run the day-to-day care, and it also works with health systems and other partners on medical facilities. Its customers are the operators and providers of care services, and its properties are concentrated in the United States, the United Kingdom and Canada. Welltower is based in Toledo, Ohio.
Welltower Inc. trades under the code 0LUS on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Welltower Inc. (0LUS) trades on the London Exchange in UK. It last closed at USD 237.10 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,186 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.3% and over the last three months it fell 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.3% | ||
| From 52-week high | -5.3% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.3% | ||
| 6-month return | 19.4% | ||
| 12-month return, skipping the last month | 33.6% | ||
| Stability (higher is calmer) | 2 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 247.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -83.4% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.21M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | +2.8% |
| 3 months | −3.3% |
| 6 months | +19.4% |
| 1 year | +37.3% |
| 3 years | +198.7% |
| 5 years | +224.5% |
Signals
| 50-day / 200-day average | 234.02 / 215.05 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Aug 2026 | USD 0.8500 |
| 12 May 2026 | USD 0.7400 |
| 25 Feb 2026 | USD 0.7400 |
| 10 Nov 2025 | USD 0.7400 |
| 11 Aug 2025 | USD 0.7400 |
| 13 May 2025 | USD 0.6700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.